Intrinsiqq
Allurion Technologies Inc. logo

Allurion Technologies Inc. Insider Trading

ALUR

⊜ Compare
Last 12 months

Insiders sold 5K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Michael R Davin sold 5K on Dec 4, 2025, 42% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2025.

Net open-market
−5K
0 buys · 1 sale
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 1
executives and directors
Last open-market buy
May 2025
May 19, 2025

Get an email when ALUR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Dec 3, 2025 – Dec 4, 2025No plan
    Michael R Davin
    Director · sold 3,212 at avg $1.53
    5K
    42% of stake
  • May 19, 2025
    Shantanu Gaur
    Chief Executive Officer · bought 8,000 at $3.06
    24K
    17% of stake
  • Mar 28, 2025
    Shantanu Gaur
    Chief Executive Officer · bought 8,000 at $3.35
    27K
    37% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ALUR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with ALUR

CompareIntrinsic value
NXGLNexGel Inc.
$4.01-10.49%30
NSPRInspireMD Inc.
$0.78+18.33%25
WOKWork Medical Technology Group Inc.
$1.04-1.89%49
BTCYBiotricity Inc.
$0.06+1.29%64
MDNCMedinotec Inc.
No recent price65
NMTCNeuroOne Medical Technologies Corporation
$0.95-3.06%40
MDAISpectral AI Inc.
$1.53+2.00%10
SNOASonoma Pharmaceuticals Inc.
$1.11-2.63%40

Spot a number that looks wrong? Check it in ALUR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ALUR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.